Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedKey updates: version bump to v3.2.0 and an important government-operating-status notice; the previous v3.1.0 reference was removed. Overall, user-facing status and versioning information were updated. If no other content changed, this is a targeted update to status and versioning.SummaryDifference2%
- Check18 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.0%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedUpdated version: v3.0.1 -> v3.0.2; removed the 'Back to Top' link.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous facility locations across various countries, particularly in Europe and Asia, while also removing some previously listed locations. Additionally, there are updates to the names of certain chemical compounds and protocols relevant to medical treatments.SummaryDifference8%
- Check61 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.0%
Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.